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E D I T O R I A L C O M M E N TA R Y

Apoptosis: Key to the Attenuated Malaria Vaccine?
Eric James
Department of Ophthalmology, Medical University of South Carolina, Charleston

(See the article by Leiriao et al., on pages 1576–81.)

Of the 12 billion people who live in areas
where malaria occurs, 1500 million are estimated to become infected each year, and
as many as 1.2 million die as a direct result,
the majority of whom are children !5
years old. Additionally, some 10,000 travelers from developed nations return home
with malaria annually. Resistance, both in
Plasmodium species to the first-line chemotherapeutic agents and in the Anopheles
mosquito vectors to insecticides, is widespread. The potential value of an antimalaria vaccine has long been recognized.
The malaria life cycle presents 3 sets of
targets for vaccine intervention, associated sequentially with invasion, erythrocyte
infection, and sexual reproduction in
the mosquito. However, malaria infection, clinical disease, and transmission all
would be prevented by a vaccine targeting only the exoerythrocytic (EEC) sporozoite and liver stages. In the quest for
a malaria vaccine, the first significant
benchmark was set in 1967, when Ruth
Nussenzweig and colleagues [1] reported
that the injection of radiation-attenuated
sporozoites of the rodent malaria parasite,
Plasmodium berghei, was capable of inducing protection against challenge in
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190% of immunized mice. Subsequent
studies, in Nussenzweig’s lab and in others, of rodent, monkey, and human forms
of malaria have established radiation-attenuated sporozoites as the “gold standard” for malaria vaccination.
In a natural infection, sporozoites injected into the skin by an infected mosquito travel through the bloodstream to
the liver sinusoids, where they actively
migrate through Kupffer cells and into
hepatocytes [2]. Inside a hepatocyte, the
sporozoite is sequestered within a parasitophorous vacuole, where it metamorphoses, feeds, and divides asexually into
numerous merozoites to form a maturing
liver schizont. Optimally irradiated sporozoites also are able to invade hepatocytes
but fail to undergo nuclear division and
development into schizonts.
A series of parasite proteins, characteristic initially of sporozoites and latterly of
developing liver and erythrocytic stages, is
expressed in the liver. Antibodies to proteins expressed by the sporozoites and
early liver-stage parasites, together with
CD8+ T cells and natural killer cells, form
the core of the host immune response to
the EEC infection [3].
Until now, it had been assumed that the
protection induced by radiation-attenuated malaria parasites was derived from
an extended period of expression of the
EEC-stage antigens by the intracellular
hepatocytic parasites. However, an additional, alternative explanation was recently suggested [4]: presentation of the

parasite antigens in the context of host
cell apoptosis. A host cell that is invaded
by a pathogen shows a natural proclivity
for undergoing apoptosis in an attempt
to prevent further development of the invader and dissemination of the infection
to new host cells. Intracellular pathogens—viruses, bacteria, and protozoa—
have evolved a remarkable array of strategies for circumventing or neutralizing
this host cell response. Attenuation induced by radiation, it was reasoned, might
be capable of abrogating the ability of a
parasite to suppress the host cell’s inclination to undergo apoptosis. Thus, host cells
infected with irradiated parasites would die
by apoptosis and be phagocytosed and processed by dendritic cells.
In this issue of the Journal of Infectious
Diseases, Leiriao et al. [5] present data that
support this hypothesis. Using the mouse
malaria parasite, P. yoelii, these authors
show that, after invasion of hepatocytes in
vivo by irradiated sporozoites, the infected
hepatocytes subsequently undergo apoptosis. This observation fits with the notion
that, with the inhibitors of host cell apoptosis disabled through irradiation of the
parasite, the infected hepatocyte dies as it
is programmed to do after invasion.
It seems likely that the apoptotic malaria
parasite–infected hepatocytes observed by
Leiriao et al. died through activation of the
intrinsic pathway of apoptosis rather than
the extrinsic death receptor–mediated or
granzyme/perforin pathways, but this remains to be confirmed. The intrinsic
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pathway of apoptosis operates through
disruption of the mitochondrial outer
membrane and activation of caspase-9,
which then activates the executioner caspases, caspase-3, -6, and -7. The extrinsic pathway is usually initiated through
activation of caspase-8 upstream of caspase-3. Leiriao et al. demonstrate strong
activity of caspase-3 in the malariainfected apoptotic hepatocytes. Other
studies have reported that the immune
response to liver-stage parasites is not abrogated in perforin-deficient or Fas-deficient mice [6], suggesting that it is unlikely that these pathways are involved.
The decline in the numbers of irradiatedparasite–infected hepatocytes in Leiriao
et al.’s study began within a few hours of
sporozoite inoculation, and parasitized
host cell numbers had already fallen to
∼20% of initial numbers by 48 h after
inoculation. Hepatocyte apoptosis thus
precedes the appearance of parasite-reactive CD8+ T cells, which become detectable 48–72 h after inoculation [7],
further suggesting that the observed hepatocyte apoptosis is unlikely to be mediated via the granzyme/perforin or extrinsic pathways triggered by activated T
cells. Under the assumption that the apoptosis seen in Leiriao et al.’s mouse hepatocytes does follow the intrinsic pathway,
this would be the first evidence that intracellular parasites attenuated by irradiation
do fail to prevent the inherent drive of the
host cell to undergo apoptosis.
Irradiation is a powerful inducer of the
intrinsic pathway of apoptosis that operates through DNA damage and up-regulated expression of p53, leading to mitochondrial disruption. This, at least, is the
pathway in mammalian cells. A process
very similar to apoptosis has been observed in protozoa [8, 9]; however, since
the molecular machinery and the apoptotic transduction pathway(s) are currently unknown for protozoa, it is not yet
possible to determine whether an apoptotic death is also the ultimate demise of
irradiated sporozoites. Even if it did not
die as a result of radiation-induced ap-

optosis, the intracellular parasite might
also be disassembled coincidently with the
host cell contents by the host apoptotic
machinery. After invasion of a hepatocyte
by an irradiated sporozoite, both parasite
and host cell, or just the host cell, could
die by apoptosis. Either way, the apoptotic
hepatocyte would be flagged for phagocytosis; however, if the parasite died without the concomitant apoptotic death of its
host hepatocyte, this antigen-presentation
pathway would not operate.
The work of Leiriao et al. additionally
provides evidence that liver dendritic cells
are recruited to phagocytose the hepatocyte corpses. This observation is also significant, since data from other systems
have indicated that dendritic cells are important for the phagocytosis and processing of apoptotic cell debris and cross-presentation of antigens for priming CD8+ T
cells [10, 11], and CD8+ T cells are critical
to the development of immunity against
an irradiated-sporozoite infection. The impetus for recruitment of dendritic cells,
as well as for their maturation, could be
provided by inflammatory mediators released by Kupffer cells and hepatocytes
wounded during the migration of sporozoites within the liver sinusoids before
the hepatocyte of choice is selected [2],
as Leiriao et al. suggest, as well as by the
apoptotic hepatocytes themselves.
Cells that have undergone apoptosis as
a consequence of normal tissue growth or
development do not release “danger signals,” and the phagocytosis of these cells
does not usually lead to the induction of
immunity [12]. However, “stressed” apoptotic cells, particularly those expressing
heat shock proteins, are very effective
stimulators of dendritic cells and activators of T cells [13, 14]. It might be
reasonable to suspect that hepatocytes
infected with radiation-attenuated sporozoites are stressed. However, even if
this is not the case, the parasite itself
could be a source of stress proteins and
other danger signals. Coincidentally, Leiriao et al. used Plasmodium Hsp70 to
monitor host cell infection and dendritic
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cell phagocytosis. Danger signals of microbial or host cell origin can function
as adjuvant molecules; therefore, if certain molecules originating from the irradiated sporozoites do assume the role
of danger signals, the vaccine organisms
could essentially provide their own adjuvants, as can occur with immunization with
bacteria. Alternatively, the danger signals
could come from those wounded Kupffer
cells and hepatocytes traversed by the sporozoites during invasion.
An issue related to vaccination using
irradiated sporozoites that remains controversial is whether the induction of protective immunity occurs centrally, through
antigen processing in the spleen and
lymph nodes, or peripherally, at the sites
where sporozoite invasion of host cells
occurs. The data presented by Leiriao et
al. provide evidence that, in the liver, the
latter scenario is at least plausible. Others
may disagree, since it is thought that only
a minority of irradiated sporozoites actually reaches the liver. Local induction
of immunity to parasite antigens through
processing of apoptotic infected host cells
by dendritic cells could, thus, be just one
component of several diverse mechanisms
of antigen processing and presentation that
are activated after inoculation with irradiated sporozoites. However, since hepatocyte
invasion is unique to the live attenuated
vaccine approach and immunization with
apoptotically derived antigens is increasingly being recognized in several systems as
a potent method of inducing protective immunity, this mechanism, involving hepatocyte apoptosis and dendritic cells, could
be what accounts for the “gold standard”
status of the radiation-attenuated–sporozoite vaccine.
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